Metastatic or Locally Advanced Breast Cancer
Also known as: Locally Advanced or Metastatic Breast Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB12218 | Capivasertib | A serine/threonine kinase inhibitor used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01101 | Capecitabine | 1 | Terminated | 1 |
DB04845 | Ixabepilone | 1 | Terminated | 1 |
DB01259 | Lapatinib | 1 | Terminated | 1 |
DB00947 | Fulvestrant | 2 | Active Not Recruiting | 1 |
DB06202 | Lasofoxifene | 2 | Active Not Recruiting | 1 |
DB12614 | Reparixin | 2 | Withdrawn | 1 |
DB17575 | Utidelone | 2 | Not Yet Recruiting | 1 |
DB18299 | N-(4-(1-cyclopropyl-4-fluoro-2-methyl-1H-benzo(d)imidazol-6-yl)-5-fluoropyrimidin-2-yl)-6-(2-(dimethylamino)ethyl)-5,6,7,8-tetrahydro-l,6-naphthyridin-2-amine | 2 / 3 | Recruiting | 2 |
DB01101 | Capecitabine | 3 | Not Yet Recruiting | 1 |
DB01248 | Docetaxel | 3 | Recruiting | 2 |
DB00947 | Fulvestrant | 3 | Recruiting | 1 |
DB06205 | Hyaluronidase (human recombinant) | 3 | Recruiting | 1 |
DB01229 | Paclitaxel | 3 | Recruiting | 1 |
DB06366 | Pertuzumab | 3 | Recruiting | 1 |
DB00072 | Trastuzumab | 3 | Recruiting | 1 |
DB00072 | Trastuzumab | 3 | Unknown Status | 1 |
DB17575 | Utidelone | 3 | Not Yet Recruiting | 1 |
DB17575 | Utidelone | 3 | Recruiting | 1 |
DB08871 | Eribulin | Not Available | Completed | 2 |